Tonix Pharmaceuticals Holding Corp.TNXPNASDAQ
LOADING
|||
Gross Profit Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
250.94%
↑ 1329% above average
Average (39q)
17.56%
Historical baseline
Range
High:1140.51%
Low:-412.14%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 250.94% |
| Q2 2025 | -185.73% |
| Q1 2025 | 6.22% |
| Q4 2024 | 10.42% |
| Q3 2024 | 209.32% |
| Q2 2024 | -241.00% |
| Q1 2024 | 1140.51% |
| Q4 2023 | -104.89% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 100.00% |
| Q4 2019 | 99.99% |
| Q3 2019 | -33.61% |
| Q2 2019 | 6.21% |
| Q1 2019 | 0.00% |
| Q4 2018 | 100.00% |
| Q3 2018 | 9.80% |
| Q2 2018 | 12.09% |
| Q1 2018 | 67.18% |
| Q4 2017 | -264.88% |
| Q3 2017 | -21.01% |
| Q2 2017 | 5.28% |
| Q1 2017 | 86.94% |
| Q4 2016 | -412.14% |
| Q3 2016 | 22.64% |
| Q2 2016 | 29.81% |
| Q1 2016 | 70.90% |
| Q4 2015 | -262.67% |